Chiltern Adopts ePharmaONE as its Site Management Platform
London, U.K., and Wilmington, N.C. - Chiltern, a leading global contract research organization, has adopted ePharmaOne™, a proprietary site management platform offered by ePharmaSolutions™, a leading provider of e-clinical solutions. This cloud-based platform improves collaboration with sites, enhances document quality and cycle times, and offers sponsors a paperless, virtual and mobile site management process with an integrated electronic trial master file. “Adding ePharmaOne to our Collaborative Technologies suite brings a new paperless approach necessary to meet regulatory standards and sponsor expectations. We continuously look to strengthen our Collaborative Approach, and this significantly improves the quality of our offerings,” said Jim Esinhart, PhD, Chiltern CEO. “We are excited to support our company focus with yet another way to make clients’ and sites’ jobs easier.” With ePharmaOne, Chiltern clients and sites will have turnkey site document management integrated with a state-of-the-art electronic trial master file (eTMF). This best-in-class technology truly gives Chiltern clients a “Designed Around You” experience. “Chiltern is leading the CRO industry in uptake of technology,” said Alison O’Neill, chief operating officer, ePharmaSolutions. “We are excited they have chosen ePharmaSolutions and are happy to be a part of their portfolio of technologies available to their clients.” The new platform provides an integrated solution for:
- Feasibility and site identification
- Secure document exchange, electronic signature and embedded document approvals
- Site learning management
- Electronic site safety letter distribution
- eTMF
Paragon Solutions, a leader in life sciences consulting services, is Chiltern’s implementation partner for ePharmaOne and has been instrumental in driving this implementation project to completion, on time and on budget. Chiltern is scheduling demos in Booth 601 at the Drug Information Association (DIA) Annual Meeting, June 26-30 in Philadelphia. See how this platform can work for your trial by
scheduling a meeting
at the show.
About Chiltern
Chiltern, a global contract research organization, is the leading mid-sized provider of clinical solutions in a variety of specialty areas and engagement models for biopharmaceutical and medical device industries. Chiltern’s team of more than 4,200, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance, Strategic Regulatory and Clinical Supplies services using a collaborative approach to maximize efficiency and minimize delays. Visit
Chiltern.com
to learn more about how Chiltern is Designed Around You.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
